N/A N=21

Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

Hepatitis C

Bottom Line

View on ClinicalTrials.gov: NCT00674492 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Mar 2015

Primary outcome: Primary: Attributes of Treatment Experience — 14; 15; 7; 9 participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: US Department of Veterans Affairs
Primary completion: Aug 2008

Outcome Measures

Outcome	Result	p-value
PRIMARY Attributes of Treatment Experience	14; 15; 7; 9	—

Summary

Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Eligibility Criteria

Inclusion Criteria

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria

none

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00674492). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.